- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Adrianne Appel2024-07-18T20:20:00
A multi-state hospice home health provider agreed to pay $19.4 million to settle allegations that it paid kickbacks and knowingly billed federal health programs to treat non-terminally ill patients.
Kindred at Home, now Gentiva, allegedly filed false claims to Medicare and/or Medicaid at its operations in Alabama, Indiana, Ohio, Rhode Island, Missouri, and Texas, the Department of Justice (DOJ) and state of Tennessee alleged in a settlement agreement, filed in U.S. District Court for the Middle District of Tennessee. The federal government will receive more than $18.9 million, Tennessee $448,000 and Ohio more than $23,000.
The case resolves claims brought under the qui tam provisions of the False Claims Act by nine former Kindred employees, who will receive an undetermined amount, the DOJ said in a press release Wednesday.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
Home health and hospice agency Intrepid USA agreed to pay $3.8 million to settle allegations, first brought by four whistleblowers, that its facilities billed Medicare for services patients were not qualified to receive, according to the Department of Justice.
Admera Health agreed to pay more than $5.5 million to resolve allegations first brought by two whistleblowers that it paid kickbacks to third-party contractors, the Department of Justice said.
DaVita, a multi-state dialysis provider, agreed to pay more than $34 million to resolve allegations it engaged in numerous kickback schemes to doctors who referred Medicare patients to its dialysis centers, the Department of Justice announced.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
